Cargando…

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE

BACKGROUND: In the current COVID-19 pandemic, the world has reached an important milestone where vaccinations are discovered and are proven to be effective against SARS-COV-2 infections. Though vaccines against COVID-19 are now available, around the globe there is some hesitancy in getting the vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahamed, Faheem, Ganesan, Subhashini, James, Anila, Zaher, Walid Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404750/ https://www.ncbi.nlm.nih.gov/pubmed/34461846 http://dx.doi.org/10.1186/s12889-021-11620-z

Ejemplares similares

Response to COVID-19 pandemic in the UAE: A public health perspective
por: Al Hosany, Farida, et al.
Publicado: (2021)

Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE—An Observational Study
por: Ganesan, Subhashini, et al.
Publicado: (2022)

COVID-19 Crisis Management: Lessons From the United Arab Emirates Leaders
por: Abbas Zaher, Walid, et al.
Publicado: (2021)

Side effects and perceptions following Sinopharm COVID-19 vaccination
por: Saeed, Balsam Qubais, et al.
Publicado: (2021)

Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE)
por: Ismail AlHosani, Farida, et al.
Publicado: (2022)

Parents’ Perception, Acceptance, and Hesitancy to Vaccinate Their Children against COVID-19: Results from a National Study in the UAE
por: Kharaba, Zelal, et al.
Publicado: (2022)

An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates
por: Holt, Stephen Geoffrey, et al.
Publicado: (2021)

Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection
por: Letafati, Arash, et al.
Publicado: (2023)

Sinopharm COVID-19 vaccine-induced Stevens–Johnson syndrome
por: Boualila, L., et al.
Publicado: (2022)

Fixed drug eruption after the Sinopharm COVID‐19 vaccine
por: Rekabi, Mahsa, et al.
Publicado: (2022)

Knowledge, Attitude, and Acceptance of Sinopharm and AstraZeneca’s COVID-19 Vaccines among Egyptian Population: A Cross-Sectional Study
por: Boshra, Marian S., et al.
Publicado: (2022)

Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination
por: Hosseinzadeh, Rezvan, et al.
Publicado: (2022)

Lethal Toxic Epidermal Necrolysis probably induced by Sinopharm COVID-19 vaccine
por: Seck, B., et al.
Publicado: (2022)

The Prevalence of Side Effects of Sinopharm COVID-19 Vaccine: An Experience From Pakistan
por: Haider, Taimur, et al.
Publicado: (2023)

Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter]
por: Shuja, Syed Hasan, et al.
Publicado: (2021)

Adverse Effects of Sinopharm COVID-19 Vaccine among Vaccinated Medical Students and Health Care Workers
por: Meo, Anusha Sultan, et al.
Publicado: (2023)

Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain
por: Jahromi, Mohamed, et al.
Publicado: (2021)

UAE efforts in promoting COVID-19 vaccination and building vaccine confidence
por: Suliman, Duaa Mohamed, et al.
Publicado: (2021)

Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2
por: Mahmoud, Sally, et al.
Publicado: (2022)

Abducense nerve palsy following BBIBP-CorV (Sinopharm) COVID-19 vaccine
por: Khalili, M.R., et al.
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
por: Boshra, Marian S., et al.
Publicado: (2022)

Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
por: Wang, Chao, et al.
Publicado: (2022)

Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm)
por: Cvetkovic-Vega, Aleksandar, et al.
Publicado: (2023)

Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine
por: Omran, Eman A., et al.
Publicado: (2022)

Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine Inoculation
por: Ma, Jing, et al.
Publicado: (2022)

Understanding COVID-19 vaccine hesitancy in Malaysia: Public perception, knowledge, and acceptance
por: Mohamed, Nurul Azmawati, et al.
Publicado: (2023)

Comparison of the Onset and End of Specific and Major Side Effects in Iranian Teenage Participants Vaccinated With COVID-19 Vaccine: Sinopharm and Soberana
por: Tavakoli, Nader, et al.
Publicado: (2023)

Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
por: Zhang, Yaowen, et al.
Publicado: (2022)

Autoimmune encephalitis after BBIBP-CorV (Sinopharm) COVID-19 vaccination: a case report
por: Vences, Miguel A., et al.
Publicado: (2022)

Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
por: Alqassieh, Rami, et al.
Publicado: (2021)

Cord blood antibodies following BBIBP‐CorV (Sinopharm) vaccination during pregnancy
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2023)

Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
por: Riazi, Ali, et al.
Publicado: (2023)

Health Belief Model and parents' acceptance of the Pfizer-BioNTech and Sinopharm COVID-19 vaccine for children aged 5–18 years Old: A national survey
por: Vatcharavongvan, Pasitpon, et al.
Publicado: (2023)

Qualitative Assessment of Early Adverse Effects of Pfizer–BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews
por: Abu-Halaweh, Sami, et al.
Publicado: (2021)

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People
por: Saeed, Umar, et al.
Publicado: (2021)

Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
por: Sistanizad, Mohammad, et al.
Publicado: (2023)

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88k9igfn42gfvgfke0361qk190